Praktisk anvendelse af knoglemarkører ved behandling af osteoporose

Abstract

Bone turnover markers (BTM) are highly responsive to initiation and changes in anti-osteoporotic therapy. In contrast to the slow treatment-induced changes in bone mineral density, the fast changes in BTM enable the clinician to adjust treatment management within a short timeframe. This review describes how BTM can be used for treatment monitoring, including monitoring during discontinuation of alendronate and denosumab therapy. In addition, sources of errors and pitfalls when using BTM monitoring will be described.

Bidragets oversatte titelClinical application of bone turnover markers in osteoporosis
OriginalsprogDansk
ArtikelnummerV07230432
TidsskriftUgeskrift for Laeger
Vol/bind186
Udgave nummer5
ISSN0041-5782
DOI
StatusUdgivet - 29 jan. 2024

Fingeraftryk

Dyk ned i forskningsemnerne om 'Praktisk anvendelse af knoglemarkører ved behandling af osteoporose'. Sammen danner de et unikt fingeraftryk.

Citationsformater